Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Arcturus CEO Ousted, Effective Immediately

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

Shares of Arcturusare down more than 8 percent in morning trading after the company announced it abruptly terminated Joseph E. Payne as president and CEO. Source: BioSpace

Continue ReadingArcturus CEO Ousted, Effective Immediately

AbbVie Plans to Hire After Doubling Cambridge R&D Facility

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

With the additional space, AbbVie will hire 15 new employees. Source: BioSpace

Continue ReadingAbbVie Plans to Hire After Doubling Cambridge R&D Facility

3 Best Biotherapeutics Stocks to Buy Right Now

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

Sometimes the biggest are also the best. That's the case for biotherapeutics stocks. Source: BioSpace

Continue Reading3 Best Biotherapeutics Stocks to Buy Right Now

Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

Alder intends to use the cash to fund the development and commercialization of eptinezumab. Source: BioSpace

Continue ReadingAlder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025

TG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patie…

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

This Phase 2 trial is a 52-week study evaluating the safety and efficacy of ublituximab at accelerated infusion times as fast as one hour. Source: BioSpace

Continue ReadingTG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patie…

EMA Drafts ‘Strengthened’ Guidance on Safety Follow-Up for Advanced Therapies

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:Drug Industry Daily

The European Medicines Agency released a draft revised guideline for safety and efficacy follow-up of advanced therapy medicinal products, including gene therapies, cell therapies and tissue engineering. Source: Drug Industry…

Continue ReadingEMA Drafts ‘Strengthened’ Guidance on Safety Follow-Up for Advanced Therapies

Teikoku, State AGs Reach Agreement to End Pay-For-Delay for Lidoderm Patches

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:Drug Industry Daily

Teikoku Pharma reached an agreement with 22 state attorneys general to end a lawsuit accusing the drugmaker of obstructing generic competition. Source: Drug Industry Daily

Continue ReadingTeikoku, State AGs Reach Agreement to End Pay-For-Delay for Lidoderm Patches

Gottlieb Pledges to Address Flu Season Supply Shortages

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:Drug Industry Daily

The FDA is working with providers, manufacturers and distributors to head off potential saline shortages during flu season, FDA Commissioner Scott Gottlieb said Thursday. Source: Drug Industry Daily

Continue ReadingGottlieb Pledges to Address Flu Season Supply Shortages

Grocery Chains Sue Generic Drugmakers, Alleging Price-Fixing Conspiracy

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:Drug Industry Daily

Three supermarket chains sued more than 20 generic drug manufacturers, including Actavis, Apotex, Mylan, Teva and Sandoz, alleging they engaged in a conspiracy to set prices. Source: Drug Industry Daily

Continue ReadingGrocery Chains Sue Generic Drugmakers, Alleging Price-Fixing Conspiracy
  • Go to the previous page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company